Is the Market Going to Go Lower?
The last month has been extremely difficult for the stock…
Sell
31
LABU Quote, Financials, Valuation and Earnings
Last price:
$75.11
Seasonality move
:
-3.81%
Day range:
$75.02 - $81.55
52-week range:
$69.61 - $152.60
Dividend yield:
0.7%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
--
Volume:
665.7K
Avg. volume:
1.2M
1-year change:
-39.73%
Market cap:
--
Revenue:
--
EPS (TTM):
--
Price Performance History
Performance vs. Valuation Benchmarks
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Competitors
| Company | Revenue Forecast | Earnings Forecast | Revenue Growth Forecast | Earnings Growth Forecast | Analyst Price Target Median |
|---|---|---|---|---|---|
|
LABU
Direxion Daily S&P Biotech Bull 3X Shares
|
-- | -- | -- | -- | -- |
|
NUGT
Direxion Daily Gold Miners Index Bull 2X Shares
|
-- | -- | -- | -- | -- |
|
ROM
ProShares Ultra Technology
|
-- | -- | -- | -- | -- |
|
UDOW
ProShares UltraPro Dow30
|
-- | -- | -- | -- | -- |
|
USD
ProShares Ultra Semiconductors
|
-- | -- | -- | -- | -- |
|
UYG
ProShares Ultra Financials
|
-- | -- | -- | -- | -- |
| Company | Price | Analyst Target | Market Cap | P/E Ratio | Dividend per Share | Dividend Yield | Price / LTM Sales |
|---|---|---|---|---|---|---|---|
|
LABU
Direxion Daily S&P Biotech Bull 3X Shares
|
$80.14 | -- | -- | -- | $0.15 | 0.7% | -- |
|
NUGT
Direxion Daily Gold Miners Index Bull 2X Shares
|
$58.68 | -- | -- | -- | $0.25 | 1.07% | -- |
|
ROM
ProShares Ultra Technology
|
$58.16 | -- | -- | -- | $0.03 | 0.25% | -- |
|
UDOW
ProShares UltraPro Dow30
|
$87.79 | -- | -- | -- | $0.15 | 1.02% | -- |
|
USD
ProShares Ultra Semiconductors
|
$49.30 | -- | -- | -- | $0.07 | 0.13% | -- |
|
UYG
ProShares Ultra Financials
|
$86.74 | -- | -- | -- | $0.20 | 0.5% | -- |
| Company | Total Debt / Total Capital | Beta | Debt to Equity | Quick Ratio |
|---|---|---|---|---|
|
LABU
Direxion Daily S&P Biotech Bull 3X Shares
|
-- | 4.050 | -- | -- |
|
NUGT
Direxion Daily Gold Miners Index Bull 2X Shares
|
-- | 0.841 | -- | -- |
|
ROM
ProShares Ultra Technology
|
-- | 2.149 | -- | -- |
|
UDOW
ProShares UltraPro Dow30
|
-- | 3.309 | -- | -- |
|
USD
ProShares Ultra Semiconductors
|
-- | 2.208 | -- | -- |
|
UYG
ProShares Ultra Financials
|
-- | 2.173 | -- | -- |
| Company | Gross Profit | Operating Income | Return on Invested Capital | Return on Common Equity | EBIT Margin | Free Cash Flow |
|---|---|---|---|---|---|---|
|
LABU
Direxion Daily S&P Biotech Bull 3X Shares
|
-- | -- | -- | -- | -- | -- |
|
NUGT
Direxion Daily Gold Miners Index Bull 2X Shares
|
-- | -- | -- | -- | -- | -- |
|
ROM
ProShares Ultra Technology
|
-- | -- | -- | -- | -- | -- |
|
UDOW
ProShares UltraPro Dow30
|
-- | -- | -- | -- | -- | -- |
|
USD
ProShares Ultra Semiconductors
|
-- | -- | -- | -- | -- | -- |
|
UYG
ProShares Ultra Financials
|
-- | -- | -- | -- | -- | -- |
Direxion Daily S&P Biotech Bull 3X Shares vs. Competitors
-
Which has Higher Returns LABU or NUGT?
Direxion Daily Gold Miners Index Bull 2X Shares has a net margin of -- compared to Direxion Daily S&P Biotech Bull 3X Shares's net margin of --. Direxion Daily S&P Biotech Bull 3X Shares's return on equity of -- beat Direxion Daily Gold Miners Index Bull 2X Shares's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital LABUDirexion Daily S&P Biotech Bull 3X Shares-- -- -- NUGTDirexion Daily Gold Miners Index Bull 2X Shares-- -- -- -
What do Analysts Say About LABU or NUGT?
Direxion Daily S&P Biotech Bull 3X Shares has a consensus price target of --, signalling downside risk potential of --. On the other hand Direxion Daily Gold Miners Index Bull 2X Shares has an analysts' consensus of -- which suggests that it could fall by --. Given that Direxion Daily S&P Biotech Bull 3X Shares has higher upside potential than Direxion Daily Gold Miners Index Bull 2X Shares, analysts believe Direxion Daily S&P Biotech Bull 3X Shares is more attractive than Direxion Daily Gold Miners Index Bull 2X Shares.
Company Buy Ratings Hold Ratings Sell Ratings LABUDirexion Daily S&P Biotech Bull 3X Shares0 0 0 NUGTDirexion Daily Gold Miners Index Bull 2X Shares0 0 0 -
Is LABU or NUGT More Risky?
Direxion Daily S&P Biotech Bull 3X Shares has a beta of 3.061, which suggesting that the stock is 206.128% more volatile than S&P 500. In comparison Direxion Daily Gold Miners Index Bull 2X Shares has a beta of 2.315, suggesting its more volatile than the S&P 500 by 131.485%.
-
Which is a Better Dividend Stock LABU or NUGT?
Direxion Daily S&P Biotech Bull 3X Shares has a quarterly dividend of $0.15 per share corresponding to a yield of 0.7%. Direxion Daily Gold Miners Index Bull 2X Shares offers a yield of 1.07% to investors and pays a quarterly dividend of $0.25 per share. Direxion Daily S&P Biotech Bull 3X Shares pays -- of its earnings as a dividend. Direxion Daily Gold Miners Index Bull 2X Shares pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios LABU or NUGT?
Direxion Daily S&P Biotech Bull 3X Shares quarterly revenues are --, which are smaller than Direxion Daily Gold Miners Index Bull 2X Shares quarterly revenues of --. Direxion Daily S&P Biotech Bull 3X Shares's net income of -- is lower than Direxion Daily Gold Miners Index Bull 2X Shares's net income of --. Notably, Direxion Daily S&P Biotech Bull 3X Shares's price-to-earnings ratio is -- while Direxion Daily Gold Miners Index Bull 2X Shares's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Direxion Daily S&P Biotech Bull 3X Shares is -- versus -- for Direxion Daily Gold Miners Index Bull 2X Shares. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income LABUDirexion Daily S&P Biotech Bull 3X Shares-- -- -- -- NUGTDirexion Daily Gold Miners Index Bull 2X Shares-- -- -- --
-
Which has Higher Returns LABU or ROM?
ProShares Ultra Technology has a net margin of -- compared to Direxion Daily S&P Biotech Bull 3X Shares's net margin of --. Direxion Daily S&P Biotech Bull 3X Shares's return on equity of -- beat ProShares Ultra Technology's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital LABUDirexion Daily S&P Biotech Bull 3X Shares-- -- -- ROMProShares Ultra Technology-- -- -- -
What do Analysts Say About LABU or ROM?
Direxion Daily S&P Biotech Bull 3X Shares has a consensus price target of --, signalling downside risk potential of --. On the other hand ProShares Ultra Technology has an analysts' consensus of -- which suggests that it could fall by --. Given that Direxion Daily S&P Biotech Bull 3X Shares has higher upside potential than ProShares Ultra Technology, analysts believe Direxion Daily S&P Biotech Bull 3X Shares is more attractive than ProShares Ultra Technology.
Company Buy Ratings Hold Ratings Sell Ratings LABUDirexion Daily S&P Biotech Bull 3X Shares0 0 0 ROMProShares Ultra Technology0 0 0 -
Is LABU or ROM More Risky?
Direxion Daily S&P Biotech Bull 3X Shares has a beta of 3.061, which suggesting that the stock is 206.128% more volatile than S&P 500. In comparison ProShares Ultra Technology has a beta of 2.354, suggesting its more volatile than the S&P 500 by 135.396%.
-
Which is a Better Dividend Stock LABU or ROM?
Direxion Daily S&P Biotech Bull 3X Shares has a quarterly dividend of $0.15 per share corresponding to a yield of 0.7%. ProShares Ultra Technology offers a yield of 0.25% to investors and pays a quarterly dividend of $0.03 per share. Direxion Daily S&P Biotech Bull 3X Shares pays -- of its earnings as a dividend. ProShares Ultra Technology pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios LABU or ROM?
Direxion Daily S&P Biotech Bull 3X Shares quarterly revenues are --, which are smaller than ProShares Ultra Technology quarterly revenues of --. Direxion Daily S&P Biotech Bull 3X Shares's net income of -- is lower than ProShares Ultra Technology's net income of --. Notably, Direxion Daily S&P Biotech Bull 3X Shares's price-to-earnings ratio is -- while ProShares Ultra Technology's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Direxion Daily S&P Biotech Bull 3X Shares is -- versus -- for ProShares Ultra Technology. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income LABUDirexion Daily S&P Biotech Bull 3X Shares-- -- -- -- ROMProShares Ultra Technology-- -- -- --
-
Which has Higher Returns LABU or UDOW?
ProShares UltraPro Dow30 has a net margin of -- compared to Direxion Daily S&P Biotech Bull 3X Shares's net margin of --. Direxion Daily S&P Biotech Bull 3X Shares's return on equity of -- beat ProShares UltraPro Dow30's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital LABUDirexion Daily S&P Biotech Bull 3X Shares-- -- -- UDOWProShares UltraPro Dow30-- -- -- -
What do Analysts Say About LABU or UDOW?
Direxion Daily S&P Biotech Bull 3X Shares has a consensus price target of --, signalling downside risk potential of --. On the other hand ProShares UltraPro Dow30 has an analysts' consensus of -- which suggests that it could fall by --. Given that Direxion Daily S&P Biotech Bull 3X Shares has higher upside potential than ProShares UltraPro Dow30, analysts believe Direxion Daily S&P Biotech Bull 3X Shares is more attractive than ProShares UltraPro Dow30.
Company Buy Ratings Hold Ratings Sell Ratings LABUDirexion Daily S&P Biotech Bull 3X Shares0 0 0 UDOWProShares UltraPro Dow300 0 0 -
Is LABU or UDOW More Risky?
Direxion Daily S&P Biotech Bull 3X Shares has a beta of 3.061, which suggesting that the stock is 206.128% more volatile than S&P 500. In comparison ProShares UltraPro Dow30 has a beta of 2.923, suggesting its more volatile than the S&P 500 by 192.291%.
-
Which is a Better Dividend Stock LABU or UDOW?
Direxion Daily S&P Biotech Bull 3X Shares has a quarterly dividend of $0.15 per share corresponding to a yield of 0.7%. ProShares UltraPro Dow30 offers a yield of 1.02% to investors and pays a quarterly dividend of $0.15 per share. Direxion Daily S&P Biotech Bull 3X Shares pays -- of its earnings as a dividend. ProShares UltraPro Dow30 pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios LABU or UDOW?
Direxion Daily S&P Biotech Bull 3X Shares quarterly revenues are --, which are smaller than ProShares UltraPro Dow30 quarterly revenues of --. Direxion Daily S&P Biotech Bull 3X Shares's net income of -- is lower than ProShares UltraPro Dow30's net income of --. Notably, Direxion Daily S&P Biotech Bull 3X Shares's price-to-earnings ratio is -- while ProShares UltraPro Dow30's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Direxion Daily S&P Biotech Bull 3X Shares is -- versus -- for ProShares UltraPro Dow30. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income LABUDirexion Daily S&P Biotech Bull 3X Shares-- -- -- -- UDOWProShares UltraPro Dow30-- -- -- --
-
Which has Higher Returns LABU or USD?
ProShares Ultra Semiconductors has a net margin of -- compared to Direxion Daily S&P Biotech Bull 3X Shares's net margin of --. Direxion Daily S&P Biotech Bull 3X Shares's return on equity of -- beat ProShares Ultra Semiconductors's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital LABUDirexion Daily S&P Biotech Bull 3X Shares-- -- -- USDProShares Ultra Semiconductors-- -- -- -
What do Analysts Say About LABU or USD?
Direxion Daily S&P Biotech Bull 3X Shares has a consensus price target of --, signalling downside risk potential of --. On the other hand ProShares Ultra Semiconductors has an analysts' consensus of -- which suggests that it could fall by --. Given that Direxion Daily S&P Biotech Bull 3X Shares has higher upside potential than ProShares Ultra Semiconductors, analysts believe Direxion Daily S&P Biotech Bull 3X Shares is more attractive than ProShares Ultra Semiconductors.
Company Buy Ratings Hold Ratings Sell Ratings LABUDirexion Daily S&P Biotech Bull 3X Shares0 0 0 USDProShares Ultra Semiconductors0 0 0 -
Is LABU or USD More Risky?
Direxion Daily S&P Biotech Bull 3X Shares has a beta of 3.061, which suggesting that the stock is 206.128% more volatile than S&P 500. In comparison ProShares Ultra Semiconductors has a beta of 2.783, suggesting its more volatile than the S&P 500 by 178.349%.
-
Which is a Better Dividend Stock LABU or USD?
Direxion Daily S&P Biotech Bull 3X Shares has a quarterly dividend of $0.15 per share corresponding to a yield of 0.7%. ProShares Ultra Semiconductors offers a yield of 0.13% to investors and pays a quarterly dividend of $0.07 per share. Direxion Daily S&P Biotech Bull 3X Shares pays -- of its earnings as a dividend. ProShares Ultra Semiconductors pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios LABU or USD?
Direxion Daily S&P Biotech Bull 3X Shares quarterly revenues are --, which are smaller than ProShares Ultra Semiconductors quarterly revenues of --. Direxion Daily S&P Biotech Bull 3X Shares's net income of -- is lower than ProShares Ultra Semiconductors's net income of --. Notably, Direxion Daily S&P Biotech Bull 3X Shares's price-to-earnings ratio is -- while ProShares Ultra Semiconductors's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Direxion Daily S&P Biotech Bull 3X Shares is -- versus -- for ProShares Ultra Semiconductors. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income LABUDirexion Daily S&P Biotech Bull 3X Shares-- -- -- -- USDProShares Ultra Semiconductors-- -- -- --
-
Which has Higher Returns LABU or UYG?
ProShares Ultra Financials has a net margin of -- compared to Direxion Daily S&P Biotech Bull 3X Shares's net margin of --. Direxion Daily S&P Biotech Bull 3X Shares's return on equity of -- beat ProShares Ultra Financials's return on equity of --.
Company Gross Margin Earnings Per Share Invested Capital LABUDirexion Daily S&P Biotech Bull 3X Shares-- -- -- UYGProShares Ultra Financials-- -- -- -
What do Analysts Say About LABU or UYG?
Direxion Daily S&P Biotech Bull 3X Shares has a consensus price target of --, signalling downside risk potential of --. On the other hand ProShares Ultra Financials has an analysts' consensus of -- which suggests that it could fall by --. Given that Direxion Daily S&P Biotech Bull 3X Shares has higher upside potential than ProShares Ultra Financials, analysts believe Direxion Daily S&P Biotech Bull 3X Shares is more attractive than ProShares Ultra Financials.
Company Buy Ratings Hold Ratings Sell Ratings LABUDirexion Daily S&P Biotech Bull 3X Shares0 0 0 UYGProShares Ultra Financials0 0 0 -
Is LABU or UYG More Risky?
Direxion Daily S&P Biotech Bull 3X Shares has a beta of 3.061, which suggesting that the stock is 206.128% more volatile than S&P 500. In comparison ProShares Ultra Financials has a beta of 2.137, suggesting its more volatile than the S&P 500 by 113.656%.
-
Which is a Better Dividend Stock LABU or UYG?
Direxion Daily S&P Biotech Bull 3X Shares has a quarterly dividend of $0.15 per share corresponding to a yield of 0.7%. ProShares Ultra Financials offers a yield of 0.5% to investors and pays a quarterly dividend of $0.20 per share. Direxion Daily S&P Biotech Bull 3X Shares pays -- of its earnings as a dividend. ProShares Ultra Financials pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios LABU or UYG?
Direxion Daily S&P Biotech Bull 3X Shares quarterly revenues are --, which are smaller than ProShares Ultra Financials quarterly revenues of --. Direxion Daily S&P Biotech Bull 3X Shares's net income of -- is lower than ProShares Ultra Financials's net income of --. Notably, Direxion Daily S&P Biotech Bull 3X Shares's price-to-earnings ratio is -- while ProShares Ultra Financials's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Direxion Daily S&P Biotech Bull 3X Shares is -- versus -- for ProShares Ultra Financials. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income LABUDirexion Daily S&P Biotech Bull 3X Shares-- -- -- -- UYGProShares Ultra Financials-- -- -- --
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
2 Dividend Stocks to Buy in a Recession
While many economists and investors initially expected 2025 to be…
Is Ford Stock Undervalued Amid the EV Transition?
There is a lot going on in the electric vehicle…
Stock Ideas
Buy
53
Is AAPL Stock a Buy?
Market Cap: $3.2T
P/E Ratio: 35x
Buy
54
Is NVDA Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 41x
Buy
51
Is MSFT Stock a Buy?
Market Cap: $2.9T
P/E Ratio: 33x
Alerts
Buy
63
EXOD alert for Mar 18
Exodus Movement [EXOD] is down 2.29% over the past day.
Sell
45
MNPR alert for Mar 18
Monopar Therapeutics [MNPR] is down 0.23% over the past day.
Sell
47
CELH alert for Mar 18
Celsius Holdings [CELH] is up 0.27% over the past day.
